Zilkha Neurogenetic Institute
About the Institute
The Zilkha Neurogenetic Institute (ZNI) is one of the Centers of Excellence at the Keck School of Medicine of USC. Established in 2003 with a gift from Selim Zilkha, the Zilkha Neurogenetic Institute is a world leader for basic neuroscience research, with a multi-disciplinary team of outstanding faculty whose collaboration concentrates on the causes, effects of and therapies for neurodegenerative disease and psychiatric disorders.
Students work with world leading researchers in various disciplines to conduct world-class bench science with some clinical applications and translational work to investigate and identify the underlying circuitry or mechanisms of the brain that are influenced or affected by neurodegenerative conditions such as Alzheimer’s, Huntington’s disease, schizophrenia, autism, Down Syndrome and hearing and visual disorders. The research experience takes place in a vibrant and dynamic community with access to a variety of state-of-the-art labs and numerous resources.
Study: A glitch in ‘gatekeeper cells’ slowly suffocates the brainAbnormality with special cells that wrap around blood vessels in the brain leads to neuron deterioration, possibly affecting the development of Alzheimer’s disease, a USC-led study reveals. “Gatekeeper cells” called pericytes surround blood vessels, contracting and dilating to control blood flow to active parts of the brain. “Pericyte degeneration may be ground zero for neurodegenerative
Herklotz Seminar Room (ZNI 112)
12:00 pm - 1:00 pm
View All ZNI Events